Literature DB >> 17058222

Sclerosing cholangitis: a focus on secondary causes.

Rupert Abdalian1, E Jenny Heathcote.   

Abstract

Secondary sclerosing cholangitis (SSC) is a disease that is morphologically similar to primary sclerosing cholangitis (PSC) but that originates from a known pathological process. Its clinical and cholangiographic features may mimic PSC, yet its natural history may be more favorable if recognition is prompt and appropriate therapy is introduced. Thus, the diagnosis of PSC requires the exclusion of secondary causes of sclerosing cholangitis and recognition of associated conditions that may potentially imitate its classic cholangiographic features. Well-described causes of SSC include intraductal stone disease, surgical or blunt abdominal trauma, intra-arterial chemotherapy, and recurrent pancreatitis. However, a wide variety of other associations have been reported recently, including autoimmune pancreatitis, portal biliopathy, eosinophillic and/or mast cell cholangitis, hepatic inflammatory pseudotumor, recurrent pyogenic cholangitis, primary immune deficiency, and AIDS-related cholangiopathy. This article offers a comprehensive review of SSC.

Entities:  

Mesh:

Year:  2006        PMID: 17058222     DOI: 10.1002/hep.21405

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 2.  Genetic epidemiology of primary sclerosing cholangitis.

Authors:  Tom-H Karlsen; Erik Schrumpf; Kirsten-Muri Boberg
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

3.  Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

Authors:  Irene Esposito; Andrea Kubisova; Adolf Stiehl; Hasan Kulaksiz; Peter Schirmacher
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

Review 4.  Genetics in PSC: what do the "risk genes" teach us?

Authors:  Trine Folseraas; Evaggelia Liaskou; Carl A Anderson; Tom H Karlsen
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis.

Authors:  Ryo Sugiura; Shunsuke Ohnishi; Masatsugu Ohara; Marin Ishikawa; Shuichi Miyamoto; Reizo Onishi; Koji Yamamoto; Kazumichi Kawakubo; Masaki Kuwatani; Naoya Sakamoto
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 6.  Controversies in the management of primary sclerosing cholangitis.

Authors:  Jeremy S Nayagam; Stephen P Pereira; John Devlin; Phillip M Harrison; Deepak Joshi
Journal:  World J Hepatol       Date:  2016-02-18

7.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

Review 8.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichiro Kato; Tadahiro Takada; Junichi Fukushima; Fukuo Kondo; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

10.  Portal hypertensive biliopathy: a rare cause of childhood cholestasis.

Authors:  Wael El-Matary; Eve A Roberts; Peter Kim; Michael Temple; Ernest Cutz; Simon C Ling
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.